Introduction: Coagulation disorder is one the most frequent complications in decompensated cirrhosis. One of the coagulation factors being impaired is fibrinogen which plays a role in bleeding complications. This study aimed to determine correlation between decompensated cirrhosis severity and plasma fibrinogen level.
Methods: This was a cross-sectional study, involving thirty-one patients which was conducted in dr. Soetomo General Hospital, Surabaya. The severity of decompensated cirrhosis was measured by Model Of End Stage Liver Disease (MELD) Score, while fibrinogen level was examined by the Sysmex CS-2100i machine.
Results: Among thirty-one subjects, the majority of subjects were male with 19 (61.2%), while female was 13 (38.8%). The patients’ mean age was 52.2 ± 8.87 years (range 27-64 years). The causes of decompensated liver cirrhosis in this study were hepatitis B (45.2%) and hepatitis C (41.9%). The median of MELD score was 11. The mean of fibrinogen level was 171.077 ± 65.3 mg/dL. There was a negative correlation between MELD score and fibrinogen level (p = 0.008; r = -0.466).
Conclusion: Decompensated cirrochis severity measured with MELD score is associated with plasma fibrinogen level.


  • Abd El-Kader SM, Al-Jiffri OH (2018) Coagulation, fibrinolytic and cytokines parameters response to weight reduction in obese subjects. European Journal of General Medicine, 15(1): 27-32. https://doi.org/10.29333/ejgm/81730
  • Amitrano L, Guardascione MA, Brancaccio V, Balzano A, (2002) Coagulation disorders in liver disease. Seminars in liver disease 22(1): 83-96. https://doi.org/10.1055/s-2002-23205
  • Annisa, Zain LH, Loesnihari R, (2018) Protection status against hepatitis B infection assessed fromanti-HBs level, history of vaccination andhistory of infection based on anti-HBc in medical students. Vol. 125. Institute of Physics Publishing https://doi.org/10.1088/1755-1315/125/1/012104
  • Arif S, Khan AS, Khan AR, (2002) Changes in fibrinogen level in liver cirrhosis. Journal of Ayub Medical College, Abbottabad : JAMC 14(2): 19-21.
  • Bacon B, (2013) Cirrhosis and its complications. In: Longo, D., Kasper, D., Jameson, J., Fauci, A., Hauser, S., Loscalzo, J. (eds.) Gastroenterology and Hepatology Harrison’s Second Edition. United States: McGraw Hill.
  • Berzigotti A, (2017) Advances and challenges in cirrhosis and portal hypertension. BMC medicine 15(1): 200. https://doi.org/10.1186/s12916-017-0966-6
  • Bogomolov PO, Macievich MV, Bueverov AO, Beznosenko VD, Petrachenkova MY, et al. (2018) Evaluation of efficacy and safety of interferon-free “3D” regimen among patients with non-compensated cirrhosis caused by HCV genotype 1b infection. Electronic Journal of General Medicine, 15(4): em37. https://doi.org/10.29333/ejgm/84989
  • Botta F, Giannini E, Romagnoli P, Fasoli A, Malfatti F, Chiarbonello B, Testa E, Risso D, Colla G, Testa R, (2003) MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut 52(1): 134-139. https://doi.org/10.1136/gut.52.1.134
  • Caldwell SH, Hoffman M, Lisman T, Macik BG, Northup PG, Reddy KR, Tripodi A, Sanyal AJ, (2006/October) Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology (Baltimore, Md.). United States https://doi.org/10.1002/hep.21303
  • Chang PE, Wong GW, Li JW, Lui HF, Chow WC, Tan CK, (2015) Epidemiology and Clinical Evolution of Liver Cirrhosis in Singapore. Annals of the Academy of Medicine, Singapore 44(6): 218-225.
  • D’Amico G, (2014) Natural History and Stages of Cirrhosis. In: Variceal Hemorrhage. New York: Springer https://doi.org/10.1007/978-1-4939-0002-2_2
  • Darmawan E, Turyadi, El-Khobar KE, Nursanty NKD, Thedja MD, Muljono DH, (2015) Seroepidemiology and occult hepatitis B virus infection in young adults in Banjarmasin, Indonesia. Journal of Medical Virology 87(2): 199-207. https://doi.org/10.1002/jmv.24045
  • de Maat MP, Nieuwenhuizen W, Knot EA, van Buuren HR, Swart GR, (1995) Measuring plasma fibrinogen levels in patients with liver cirrhosis. The occurrence of proteolytic fibrin(ogen) degradation products and their influence on several fibrinogen assays. Thrombosis research 78(4): 353-362. https://doi.org/10.1016/0049-3848(95)91463-u
  • Desborough MJR, Kahan BC, Stanworth SJ, Jairath V, (2017/March) Fibrinogen as an independent predictor of mortality in decompensated cirrhosis and bleeding. Hepatology (Baltimore, Md.). United States https://doi.org/10.1002/hep.28915
  • Drolz A, Horvatits T, Roedl K, Rutter K, Staufer K, Kneidinger N, Holzinger U, Zauner C, Schellongowski P, Heinz G, Perkmann T, Kluge S, Trauner M, Fuhrmann V, (2016) Coagulation parameters and major bleeding in critically ill patients with cirrhosis. Hepatology (Baltimore, Md.) 64(2): 556-568. https://doi.org/10.1002/hep.28628
  • Durand F, Valla D, (2005) Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. Journal of hepatology 42 Suppl(1): S100-7. https://doi.org/10.1016/j.jhep.2004.11.015
  • Francis RBJ, Feinstein DI, (1984) Clinical significance of accelerated fibrinolysis in liver disease. Haemostasis 14(6): 460-465. https://doi.org/10.1159/000215106
  • Fallah S, Seifi M, Firoozrai M, Godarzi M, Jafarzadeh M, Ghohari L.H. (2009). Influence of Apo E Polymorphism on Coronary Artery Disease. World Academy of Science, Engineering and Technology. 57 :580 -584.
  • Giard J-M, Terrault NA, (2016) Women with Cirrhosis: Prevalence, Natural History, and Management. Gastroenterology clinics of North America 45(2): 345-358. https://doi.org/10.1016/j.gtc.2016.02.010
  • Gunardi H, Iskandar MY, Turyadi, Ie SI, Dwipoerwantoro PG, Gani RA, Muljono DH, (2017) Hepatitis B virus infection in children of HBV-related chronic liver disease patients: a study of intra-familial HBV transmission. Hepatology International 11(1): 96-104. https://doi.org/10.1007/s12072-016-9764-z
  • Hassan H, Ansari AK, Memon SF, (2017) Haemostatic Abnormalities in Patients with Cirrhosis and their Relation with Severity of Liver Dysfunction as Assessed by Child Pugh Score. Journal of the Liaquat University of Medical and Health Sciences 16: 108-113. https://doi.org/10.22442/jlumhs.171620516
  • Kwong AJ, Lai JC, Dodge JL, Roberts JP, (2015) Outcomes for liver transplant candidates listed with low model for end-stage liver disease score. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 21(11): 1403-1409. https://doi.org/10.1002/lt.24307
  • Leebeek FWG, Rijken DC, (2015) The Fibrinolytic Status in Liver Diseases. Seminars in thrombosis and hemostasis 41(5): 474-480. https://doi.org/10.1055/s-0035-1550437
  • Liaw Y-F, Sollano JD, (2006) Factors influencing liver disease progression in chronic hepatitis B. Liver International 26(S2): 23-29. https://doi.org/10.1111/j.1478-3231.2006.01372.x
  • Lisman T, Ariëns RAS, (2016) Alterations in Fibrin Structure in Patients with Liver Diseases. Seminars in thrombosis and hemostasis 42(4): 389-396. https://doi.org/10.1055/s-0036-1572327
  • Lovena A, Miro S, Efrida E, (2017) Karakteristik Pasien Sirosis Hepatis di RSUP Dr. M. Djamil Padang. Jurnal Kesehatan Andalas 6(1): 5-12. https://doi.org/10.25077/jka.v6i1.636
  • Lubis HP, Halim B, Adenin I, Rusda M, Prasetiawan E, (2018) Hepatitis B virus infection on male partner has negative impact on in-vitro fertilization. In: IOP Conference Series Earth and Environmental Science Vol. 125. Institute of Physics Publishing https://doi.org/10.1088/1755-1315/125/1/012045
  • Marselina NMT, Purnomo HD, (2014) Gambaran Klinis Pasien Sirosis Hati: Studi Kasus Di Rsup Dr Kariadi Semarang Periode 2010-2012. Jurnal Kedokteran Diponegoro 3(1).
  • Nasir M, Ratnasari N, Bayupurnama P, (2013) Relationship between plasma fibrinogen levels with model of end stage liver disease score in patients with liver cirrhosis. Acta Interna: The Journal of Internal Medicine 3(2): 53-56. https://doi.org/acta%20interna.4999
  • Pase MA, Gatot D, Lindarto D, (2018) Association of fibrinogen with HbA1C in diabetic foot ulcer. Vol. 125. Institute of Physics Publishing https://doi.org/10.1088/1755-1315/125/1/012165
  • Shah NL, Caldwell SH, (2016) Assessing the risk of bleeding and clotting in cirrhosis. Clinical liver disease 7(2): 26-28. https://doi.org/10.1002/cld.528
  • Tanadi MR, Lusida MI, Joewono HT, (2017) Proportion of HBsAg AND HBeAg Positive In Maternal Patients And Their HBsAg Positives Babies With Immunoprophylaxis Of Hbv Immunization In Dr. Soetomo General Hospital, Surabaya. Indonesian Journal of Tropical and Infectious Disease 6(4): 79-83. https://doi.org/10.20473/ijtid.v6i4.1372
  • Thakrar S V, Mallett S V, (2017) Thrombocytopenia in cirrhosis: Impact of fibrinogen on bleeding risk. World journal of hepatology 9(6): 318-325. https://doi.org/10.4254/wjh.v9.i6.318
  • Tripodi A, Mannucci PM, (2011) The coagulopathy of chronic liver disease. The New England journal of medicine 365(2): 147-156. https://doi.org/10.1056/NEJMra1011170
  • Tsochatzis EA, Bosch J, Burroughs AK, (2014) Liver cirrhosis. Lancet (London, England) 383(9930): 1749-1761. https://doi.org/10.1016/S0140-6736(14)60121-5
  • Wungu CDK, Amin M, Ruslan SEN, Purwono PB, Kholili U, Maimunah U, Setiawan PB, Lusida MI, Soetjipto S, Handajani R, (2019) Detection Of Tumor Necrosis Factor-α (Tnf- α) Gene Promoters Polymorphism Among Liver Cirrhosis Patients With Chronic Hepatitis B Virus (Hbv) Infection In Surabaya, Indonesia. Indonesian Journal of Tropical and Infectious Disease 7(5): 115-121. https://doi.org/10.20473/ijtid.v7i5.7275


This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.